Evidence map›Paper›PMID 42838948›Full record

ArticleNature communications2026

Cobalt-catalyzed Markovnikov-selective hydrophosphonylation of unactivated alkenes enabled by phthalimidyl phosphite reagents.

Xinru Lin, Hanche Fei, Zhuyong Zhang, Linxiang Chai, Lin Zhu, Chaozhong Li

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xinru LinCollege of Rare Earths, Jiangxi University of Science and Technology, Ganzhou, China.
Hanche FeiState Key Laboratory of Fluorine and Nitrogen Chemistry and Advanced Materials, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
Zhuyong ZhangState Key Laboratory of Fluorine and Nitrogen Chemistry and Advanced Materials, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
Linxiang ChaiCollege of Rare Earths, Jiangxi University of Science and Technology, Ganzhou, China. chailinxiang@sioc.ac.cn.ORCID http://orcid.org/0009-0003-4401-114X
Lin ZhuState Key Laboratory of Fluorine and Nitrogen Chemistry and Advanced Materials, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China. zhulin@sioc.ac.cn.ORCID http://orcid.org/0000-0003-4174-8536
Chaozhong LiCollege of Rare Earths, Jiangxi University of Science and Technology, Ganzhou, China. clig@mail.sioc.ac.cn.ORCID http://orcid.org/0000-0002-5135-9115

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22193014
6 · The paper itself

Abstract

Alkene hydrophosphonylation constitutes an indispensable tool for the synthesis of alkylphosphonates which have found widespread applications in pharmaceuticals, agrochemicals and materials science. Although numerous methods for alkene hydrophosphonylation have been reported, achieving Markovnikov selectivity with unactivated alkenes remains a formidable challenge. Herein we report the development of a class of phosphites featuring a unique N-O-P linkage, namely dialkyl phthalimidyl phosphites, which serve as efficient radical trapping reagents. Using dialkyl phthalimidyl phosphites as phosphonylating reagents and diphenylsilane as the hydrogen donor, the cobalt-catalyzed reaction of unactivated alkenes proceeds smoothly at room temperature, delivering exclusively Markovnikov hydrophosphonylation products in satisfactory yields. Notably, the transformation exhibits excellent functional group tolerance, enabling late-stage modification of drug derivatives. A mechanism involving cobalt hydride-mediated hydrogen atom transfer, alkyl radical addition to phosphites, β-scission of phosphoranyl radicals and oxidation of Co

Identifiers

PMID42838948
PMCPMC13642914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.